Hematopoietic cell transplantation for non-Hodgkin's lymphoma: Yesterday, today, and tomorrow

被引：17

作者：

Appelbaum, Frederick R. ^{[1
,2
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[2] Univ Washington, Seattle, WA 98195 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 18期

关键词：

D O I：

10.1200/JCO.2007.15.7479

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2927 / 2929

页数：3

共 25 条

[1]

Appelbaum F R, 1983, Hematol Oncol, V1, P149

[2]

APPELBAUM FR, 1978, BLOOD, V52, P85

[3]

APPELBAUM FR, 1981, BLOOD, V58, P509

[4] REVIEW OF THE USE OF MARROW TRANSPLANTATION IN THE TREATMENT OF NON-HODGKINS LYMPHOMA [J].

APPELBAUM, FR ;

THOMAS, ED .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (07) :440-447

[5] Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation [J].

Baron, Frederic ;

Storb, Rainer ;

Storer, Barry E. ;

Maris, Michael B. ;

Niederwieser, Dietger ;

Shizuru, Judith A. ;

Chauncey, Thomas R. ;

Bruno, Benedetto ;

Forman, Stephen J. ;

McSweeney, Peter A. ;

Maziarz, Richard T. ;

Pulsipher, Michael A. ;

Agura, Edward D. ;

Wade, James ;

Sorror, Mohamed ;

Maloney, David G. ;

Sandmaier, Brenda M. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) :4150-4157

[6] High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol [J].

Brice, P ;

Simon, D ;

Bouabdallah, R ;

Bélanger, C ;

Haïoun, C ;

Thieblemont, C ;

Tilly, H ;

Harousseau, JL ;

Doyen, C ;

Martin, C ;

Brousse, N ;

Solal-Céligny, P .

ANNALS OF ONCOLOGY, 2000, 11 (12) :1585-1590

[7] Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells [J].

Corradini, P ;

Dodero, A ;

Zallio, F ;

Caracciolo, D ;

Casini, M ;

Bregni, M ;

Narni, F ;

Patriarca, F ;

Boccadoro, M ;

Benedetti, F ;

Rambaldi, A ;

Gianni, AM ;

Tarella, C .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2172-2176

[8] High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS [J].

Deconinck, E ;

Foussard, C ;

Milpied, N ;

Bertrand, P ;

Michenet, P ;

Cornillet-LeFebvre, P ;

Escoffre-Barbe, M ;

Maisonneuve, H ;

Delwail, V ;

Gressin, R ;

Legouffe, E ;

Vilque, JP ;

Desablens, B ;

Jaubert, J ;

Ramee, JF ;

Jenabian, A ;

Thyss, A ;

Le Pourhiet-Le Mevel, A ;

Travade, P ;

Delepine, R ;

Colombat, P .

BLOOD, 2005, 105 (10) :3817-3823

[9] Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network [J].

Dreyling, M ;

Lenz, G ;

Hoster, E ;

Van Hoof, A ;

Gisselbrecht, C ;

Schmits, R ;

Metzner, B ;

Truemper, L ;

Reiser, M ;

Steinhauer, H ;

Boiron, JM ;

Boogaerts, MA ;

Aldaoud, A ;

Silingardi, V ;

Kluin-Nelemans, HC ;

Hasford, J ;

Parwaresch, R ;

Unterhalt, M ;

Hiddemann, W .

BLOOD, 2005, 105 (07) :2677-2684

[10] High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma [J].

Gopal, AK ;

Rajendran, JG ;

Petersdorf, SH ;

Maloney, DG ;

Eary, JF ;

Wood, BL ;

Gooley, TA ;

Bush, SA ;

Durack, LD ;

Martin, PJ ;

Matthews, DC ;

Appelbaum, FR ;

Bernstein, ID ;

Press, OW .

BLOOD, 2002, 99 (09) :3158-3162

← 1 2 3 →